Hypovitaminosis D in patients suffering from morbid obesity: Effects of bariatric surgery;Hipovitaminosis D en pacientes afectos de obesidad mórbida: Efectos de la cirugía bariátrica

Revista Espanola de Obesidad

Volumn 4, Issue 5, 2006, Pages 275-283

  Sánchez Hernández, Joan ^a,b   Ybarra, Juan ^b,c   Pérez, Antonio ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c CENTRO MÉDICO TEKNON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCIUM; VITAMIN D;

BARIATRIC SURGERY; COST; HUMAN; MORBIDITY; OBESITY; PREVALENCE; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WEIGHT REDUCTION;

EID: 33751324745     PISSN: 16966112     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Chapin BL, LeMar HJ, Knodel DH, Carter PL. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg 1996; 113: 1048-52.
2. Guangiroli M. Cirugías malabsortivas. Facultad Favoloro Argentina Press: Argentina 2004.
3. Marsh M, Ryley S. Enfermedades gastrointestinales y hepáticas. Panamericana 1998; cap 87: 1577-608.
4. Goldner W, O'Dorisio T, Dillon J, Mason E. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg 2002; 12: 685-92.
5. Basha B, Rao S, Han Z, Parfitt M. Osteomalacia due to vitamin D depletion: A neglected consequence of intestinal malabsorption. Am J Med 2000; 108: 296-300.
6. Kawashima H, Kurokawa K. Metabolism and sites of action of vitamin D in the kidney. Kidney Int 1986, 29: 98-107.
7. Kumar R. The metabolism and mechanism of action of 1,25-dihydroxyvitamin D3. Kidney Int 1986; 30: 793-803.
8. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989, 320: 980-91.
9. Norman AW, Roth J, Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium brinding proteins) Endocr Rev 1982, 3: 331-66.
10. DeLuca HF, Krisinger J, Darwish H. The vitamin D system: 1990. Kidney Int 1990, 38 (suppl 29): S2-8.
11. MacIntyre I, Alevizaki M, Bevis PJR, Zaidi M. Calcitonin and the peptides from the calcitonine gene. Clin Orthop Relat Res 1987; 217: 45-55.
12. Delmez JA, Slatopolsky E. Recent advances in the pathogenesis and therapy of uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1991; 72: 735-9.
13. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Rev 2001; 22: 477-501.
14. MacKenna M, Freaney R. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 1998; 8 (Suppl.): S3-6.
15. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Nutr 2000; 72: 690-3.
16. Holick. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002, 9: 87-98.
17. Chapuy MC, Shott AM, Garnero P, Hans D, Delmas PD, Meunier PJ. Healthy elderly French women living at home have secondary hyperparathyroidismand high bone turnover in winter. Endocrinol Metab 1996; 81: 1129-33.
18. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370-3.
19. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int 1988; 43: 199-201.
20. Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TRE. Vitamin D status and bone histomorphometry in gross obesity. Am J Nutr 1981; 34: 2359-63.
21. Hey HE, Stockholm KH, Lun BJ, Sorensen OH. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolism following jejunoileal bypass. Int J Obes 1982; 6: 473-9.
22. Hyldstrup L, Andersen T, McNair P, Breum L, Transbol I. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol 1993; 129: 393-8.
23. Ybarra J, Sánchez-Hernández J, Gich I, De Leiva A, Rius X, Rodríguez-Espinosa J, et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg 2005; 15: 330-5.
24. Sacondarynchez-Hernacondaryndez J, Ybarra J, Gich I, De Leiva A, Rius X, Rodricondaryguez-Espinosa J, et al. Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes Surg 2005; 15: 1389-95.
25. Buffington C, Walker B, Cowan GS Jr, Scruggs D. Vitamin D Deficiency in the Morbidly Obese. Obes Surg 1993; 3: 421-4.
26. Heaney RP, Davies KM, Barger-Lux MJ. Calcium and weight: clinical studies. J Am Coll Nutr 2002; 21: 152S-5S.
27. th Tromso study. Eur J Endocrinol 2004; 151: 167-72.
28. Liu S, Song y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005; 12: 2926-32.
29. Holick MF. Calcium and vitamin D. Diagnostics and therapeutics. Clin Lab Med 2000; 20: 569-90.
30. De Frisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med 2005; 118: 51-7.
31. Ping-Delfos WC, Soares MJ, Cummings NK. Acute suppression of spontaneous food intake following dairy calcium and vitamin D. Asia Pac J Clin Nutr. 2004; 13 (Suppl): S82.
32. Compston JE, Vedi S, Gianetta E, Watson G, Civalleri D, Scopinaro N. Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology. 1984; 87: 350-6.
33. Scopinaro N, Adami GF, Marinari G, Traverso E, Papadia F, Camerini G. Biliopancreatic Diversion: Two decades of experience. In Update: Surgery for the morbidly obese patient 2000. chapter 23: 227-58.
34. Guney E, Kisakol G, Yilmaz C, Yilmaz R, Kabalak T. Effect of weight loss on bone metabolism: Comparison of vertical banded gastroplasty and medical intervention. Obes Surg 2003; 13: 383-8.
35. Teitelbaum SL, Halverson JD, Bates M, Wise L, Haddad JG. Abnormalities of circulating 25-OH vitamin D after jejuno-ileal bypass for obesity. Ann Intern Med 1977; 86: 289-93.
36. Fumarola D. Bone disease after jejunoileal bypass. Lancet 1978; 2: 678.
37. Parfitt AM, Miller JM, Frame B, Villanueva AR, Rao DS, Oliver I, et al. Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med 1978; 89: 193-9.
38. Hey H, Stokholm KH, Lund B, Lund B, Sorensen OH. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes 1982; 6: 473-9.
39. Hamoui N, Kim K, Anthone G, Crookes PF. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 2003; 138: 891-7.
40. Newbury L, Hlth B, Nurs B, Dolan K, Hatzifotis M, Low N, et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 2003; 13: 893-5.
41. Alborzi F, Leibowitz AB. Inmobilization hypercalcemia in critical illness following bariatric surgery. Obes Surg 2002; 12: 871-73.